|
Get to know highest-storage temperature Esperoct®
[antihemophilic factor (recombinant), glycopegylated-exei]
|
View online
|
|
|
|
|
|
Esperoct®
is used to treat and prevent or reduce the
number of bleeding episodes in people with
hemophilia A.
|
|
|
|
|
Beat the heat with Esperoct®
|
|
The only extended half-life product that handles
temperatures from 86°F up to 104°F.a
|
|
|
|
|
|
Life takes you on all kinds of adventures…through all kinds of
weather! Explore our interactive map to learn something new (and
surprising) about every US region—and discover why you’ll
want Esperoct® as
your treatment for hemophilia A in the passenger seat.
|
|
|
|
|
aFor up to 3 months
|
|
Scroll to learn more about how Esperoct®
can help you handle the heat.
|
|
|
|
Selected Important Safety Information
|
|
Who should not use Esperoct®?
|
| |
•
|
You should not use Esperoct®
if you are allergic to factor VIII or any of the
other ingredients of Esperoct®
or if you are allergic to hamster proteins
|
|
|
What is the most important information I need to know about
Esperoct®?
|
| |
•
|
Do not attempt to do an infusion yourself
unless you have been taught how by your
healthcare provider or hemophilia treatment
center
|
|
| |
•
|
Call your healthcare provider right away or
get emergency treatment right away if you
get any signs of an allergic reaction, such
as:
hives, chest tightness, wheezing, dizziness,
difficulty breathing, and/or swelling of the
face
|
|
|
Please
click here
or scroll below for additional Important Safety Information.
|
|
|
|
When the temperature rises, count on Esperoct®
as your hemophilia A treatment
|
|
|
No matter the season, keeping your factor cool is something
you often have to plan for. That’s where Esperoct®
comes in. Whether you’re enjoying a day at the beach
or going through an unexpected power outage at home,
Esperoct®
can take the heat.
|
|
|
|
|
|
Connect with your local Hemophilia Community Liaison (HCL)
|
|
Our HCLs are experienced, active in the hemophilia
community, and can help you learn more about Esperoct®.
|
|
|
|
|
|
|
What is Esperoct®?
|
|
Esperoct®
[antihemophilic factor (recombinant), glycopegylated-exei]
is an injectable medicine to treat and prevent or reduce the
number of bleeding episodes in people with
hemophilia A. Your healthcare provider may give you
Esperoct®
when you have surgery
|
| |
•
|
Esperoct®
is not used to treat von Willebrand Disease
|
|
|
Important Safety Information (cont’d)
|
|
What should I tell my healthcare provider before using
Esperoct®?
|
|
|
•
|
Before taking Esperoct®, you should tell your healthcare provider if
you have or have had any medical conditions,
take any medicines (including non-prescription
medicines and dietary supplements), are nursing,
pregnant or planning to become pregnant, or have
been told that you have inhibitors to factor
VIII
|
| |
•
|
Your body can make antibodies called
“inhibitors” against Esperoct®, which may stop Esperoct®
from working properly.
Call your healthcare provider right away if
your bleeding does not stop after taking
Esperoct®
|
|
|
What are the possible side effects of Esperoct®?
|
| |
•
|
Common side effects of Esperoct®
include rash or itching, and swelling, pain,
rash or redness at the location of infusion
|
|
|
Please
click here
for Prescribing Information.
|
|
Esperoct®
is a prescription medication.
|
|
You are encouraged to report negative side effects of
prescription drugs to the FDA. Visit
www.fda.gov/medwatch, or call
1-800-FDA-1088.
|
|
|
|
Please do not respond to this email. If you would like to contact us, please
click here
or call
1-877-744-2579.
|
|
UNSUBSCRIBE NOTICE
|
|
If you no longer want to receive communications from
Novo Nordisk, the sponsor of this content, click here
tounsubscribe. You also may call Novo Nordisk at
1.877.744.2579
or send a letter that includes your full contact
information (e.g. name, email address, phone) to Novo
Nordisk, 800 Scudders Mill Road, Plainsboro, New Jersey
08536. To better understand how Novo Nordisk values your
privacy, see the
Privacy Statement.
|
|
Esperoct®
is a registered trademark of Novo Nordisk Health Care
AG.
Novo Nordisk is a registered trademark of Novo
Nordisk A/S.
© 2021 Novo
Nordisk All rights reserved.
US21ESP00041
June 2021
|
|
|
|
|
